Vyvanse, Strattera, and ADHD med trial-and-error: what's real

What did @taloredwardspov actually say?

Honestly? The transcript here is a clip from what appears to be a Dance Moms pyramid scene, not a medication discussion. The actual spoken words are about Maddie going "three for three" and Kendall not sticking out. The real ADHD content lives in the caption, where the creator says they have been "sticking with Vyvanse and Strattera for the most part" after a trial-and-error process with multiple medications.

That caption framing, that "everyone is different" and that multiple medications were tested before landing on a combination, is what this fact-check is actually assessing. Because 598,000 views means a lot of people are taking medication cues from it, even if the video itself is technically a dance competition clip.

Does the science back up the Vyvanse and Strattera combination?

Yes, more than you might expect, though with real caveats. Vyvanse (lisdexamfetamine) is an FDA-approved stimulant for ADHD with strong efficacy data. Strattera (atomoxetine) is a non-stimulant, a selective norepinephrine reuptake inhibitor, also FDA-approved for ADHD. Combining them is not standard first-line treatment, but it is not fringe either.

A 2014 study by Treuer et al. in the Journal of Child and Adolescent Psychopharmacology found atomoxetine added to stimulant therapy showed benefit in patients with incomplete stimulant response. Separate meta-analyses of lisdexamfetamine consistently show large effect sizes for inattention and hyperactivity in adults (Coghill et al., 2017, CNS Drugs). The combination approach, using a stimulant plus a non-stimulant, is sometimes used when one drug alone does not address all symptom domains, particularly emotional dysregulation and anxiety co-morbidities that atomoxetine can help with.

The trial-and-error framing is also scientifically accurate. There is no reliable biomarker to predict which ADHD medication will work for a given person. Pharmacogenomic testing exists but has mixed clinical utility in real practice.

What did they get wrong, or right?

The creator does not actually make any medical claims in the transcript, so there is nothing directly wrong to call out from the spoken content. The caption gets credit for being honest about uncertainty. "Trial and error because everyone is different" is genuinely how ADHD pharmacotherapy works for a large percentage of patients, and saying so publicly does a service to people who feel like they failed because their first medication did not work.

The potential issue is contextual. Showing a long list of medications tried, without any discussion of risks or why they were discontinued, can subtly normalize polypharmacy experimentation. Strattera in particular carries an FDA black box warning about suicidal ideation in children and adolescents. Vyvanse carries cardiovascular and psychiatric risk disclosures. A 598K-view post that says "I tried all of these" without any context on safety monitoring or prescriber involvement could lead followers to self-direct complex medication decisions, which is where this kind of content crosses from relatable into potentially harmful.

What should you actually know?

If you are an adult with ADHD who has tried multiple medications without success, you are not alone and you are not broken. Studies suggest roughly 20-30% of ADHD patients have an inadequate response to their first stimulant trial (Cortese et al., 2018, Lancet Psychiatry). Switching or augmenting is medically legitimate.

But the combination of Vyvanse and Strattera is not something to pursue because a TikTok creator found it helpful. Both drugs affect the cardiovascular system and central nervous system. Atomoxetine has a delayed onset of 4-8 weeks, meaning patients and providers need time and monitoring to assess benefit. And the interaction profile between the two requires oversight because lisdexamfetamine is a Schedule II controlled substance.

The larger point is that the creator is sharing a personal outcome, not a treatment recommendation. That distinction matters enormously when viewers are trying to figure out what to ask their doctor, or worse, what to order online. Telehealth platforms that manage ADHD medications are required to conduct proper evaluations before prescribing, and any combination therapy should involve documented follow-up, not just pattern-matching to someone's social media caption.